Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 25;22(1):284.
doi: 10.1186/s12879-022-07285-7.

Evaluation of saliva self-collection devices for SARS-CoV-2 diagnostics

Affiliations

Evaluation of saliva self-collection devices for SARS-CoV-2 diagnostics

Orchid M Allicock et al. BMC Infect Dis. .

Abstract

Background: There is an urgent need to expand testing for SARS-CoV-2 and other respiratory pathogens as the global community struggles to control the COVID-19 pandemic. Current diagnostic methods can be affected by supply chain bottlenecks and require the assistance of medical professionals, impeding the implementation of large-scale testing. Self-collection of saliva may solve these problems, as it can be completed without specialized training and uses generic materials.

Methods: We observed 30 individuals who self-collected saliva using four different collection devices and analyzed their feedback. Two of these devices, a funnel and bulb pipette, were used to evaluate at-home saliva collection by 60 individuals. SARS-CoV-2-spiked saliva samples were subjected to temperature cycles designed to simulate the conditions the samples might be exposed to during the summer and winter seasons and sensitivity of detection was evaluated.

Results: All devices enabled the safe, unsupervised self-collection of saliva. The quantity and quality of the samples received were acceptable for SARS-CoV-2 diagnostic testing, as determined by human RNase P detection. There was no significant difference in SARS-CoV-2 nucleocapsid gene (N1) detection between the freshly spiked samples and those incubated with the summer and winter profiles.

Conclusion: We demonstrate inexpensive, generic, buffer free collection devices suitable for unsupervised and home saliva self-collection.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Collection devices are inexpensive, easy to use, and yield testable samples. Survey responses were reported from strongly disagree to strongly agree. a The four collection devices tested are inexpensive and provide users with a range of features to choose from. Prices at time of publication are shown in US dollars. b Participants reported being self-sufficient and confident in their ability to correctly collect saliva samples (from Additional file 2: Fig. S2). The questions are displayed above the corresponding graphs. The percentage response value for each device is shown above each bar. Two sets of participant responses were excluded because one participant did not provide a response for all four devices and one did not understand the response scale. P pipette tip, C collection aid, F funnel, B bulb pipette
Fig. 2
Fig. 2
At-home saliva collection kit components suitable for sample collection. a Each of the participants were sent an at-home collection kit comprised of either a funnel (i) or bulb pipette (ii) with a labeled screw-cap tube (iii), patient identifier sticker (iv), biohazard collection bag with absorbent sheet (v), FedEx UN 3373 Pak (vi), an alcohol pad (vii), and box for return shipment (viii). b Participant confidence in at-home self-collection of saliva when using either a funnel or bulb pipette (from Additional file 4: Fig. S4). Survey responses were reported on a scale of 1 (strongly disagree) to 5 (strongly agree). Overall, there was no significant difference between the collection devices in relation to the participant’s confidence and ability to use either device. The questions are displayed above the corresponding graphs. F funnel, B bulb pipette
Fig. 3
Fig. 3
The quality of the samples was adequate for testing with a PCR-based assay. Laboratory survey questions pertaining to the quality of the samples are shown on the x-axis (from Additional files 3 and 5). Data points represent the mean response, green dots represent samples collected from the pilot study and blue dots represent samples collected from the at-home collection kit. Survey responses were reported on a scale of 1 (strongly disagree) to 5 (strongly agree). Samples with less favorable responses are highlighted in red. Mean and standard deviation (st. dev.) are shown in black. The graph on the right shows the cycle threshold (Ct) values for the internal control RNAse P (RP) from each of the saliva samples submitted. The dots represent Ct value per participant. Ct values over 35 are considered invalid and are highlighted in gray. P-value is shown using one-way Mann–Whitney. Mean and standard deviation (st. dev.) are shown in black
Fig. 4
Fig. 4
SARS-CoV-2 detection in saliva remains stable following summer and winter shipping conditions. Spiked saliva samples diluted twofold were incubated under summer or winter profiles in triplicate (from Additional file 8: Table S3). Summer profile consisted of 40 °C for 8 h, room temperature for 4 h, 40 °C for 2 h, 28 °C for 36 h, and 40 °C for 6 h. Winter profile consisted of − 20 °C for 8 h, room temperature for 4 h, − 20 °C for 2 h, 4 °C for 36 h, and − 20 °C for 6 h. Samples with invalid Ct values are highlighted in red. No significant differences were found in N1 Ct values when comparing the profiles to the fresh (control) samples (Kruskal–Wallis; P > 0.05). b The Ct values for RP of samples for the winter profile were significantly higher than fresh samples (Kruskal–Wallis; P < 0.03). The horizontal bars indicate the median Ct value

Update of

References

    1. Hanson KE, Barker AP, Hillyard DR, Gilmore N, Barrett JW, Orlandi RR, et al. Self-collected anterior nasal and saliva specimens versus health care worker-collected nasopharyngeal swabs for the molecular detection of SARS-CoV-2. J Clin Microbiol. 2020;58(11):e0182420. doi: 10.1128/JCM.01824-20. - DOI - PMC - PubMed
    1. Wong SCY, Tse H, Siu HK, Kwong TS, Chu MY, Yau FYS, et al. Posterior oropharyngeal saliva for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Clin Infect Dis. 2020;71(11):2939–2946. doi: 10.1093/cid/ciaa797. - DOI - PMC - PubMed
    1. Wyllie AL, Fournier J, Casanovas-Massana A, Campbell M, Tokuyama M, Vijayakumar P, et al. Saliva or nasopharyngeal swab specimens for detection of SARS-CoV-2. N Engl J Med. 2020;383(13):1283–1286. doi: 10.1056/NEJMc2016359. - DOI - PMC - PubMed
    1. Tan SH, Allicock O, Armstrong-Hough M, Wyllie AL. Saliva as a gold-standard sample for SARS-CoV-2 detection. Lancet Respir Med. 2021;9(6):562–564. doi: 10.1016/S2213-2600(21)00178-8. - DOI - PMC - PubMed
    1. Vogels CBF, Watkins AE, Harden CA, Brackney DE, Shafer J, Wang J, et al. SalivaDirect: a simplified and flexible platform to enhance SARS-CoV-2 testing capacity. Med (N Y) 2021;2(3):263–80.e6. - PMC - PubMed

Substances